X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-09 | LMAT | Lemaitre Vascular Inc | Pellegrino Joseph P Jr | CFO | S - Sale+OE | $54.26 | -34,738 | 6,108 | -85% | -$1,884,740 | |||||
2022-08-09 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $5.12 | -10,000 | 172,665 | -5% | -$51,194 | ||||||
2022-08-09 | MDXG | Mimedx Group, Inc. | Kashyap Rohit | Pres, WC, Surgical | S - Sale | $4.21 | -12,343 | 430,072 | -3% | -$51,939 | ||||||
| M | 2022-08-09 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | S - Sale | $14.12 | -158,412 | 1,171,881 | -12% | -$2,237,478 | |||||
2022-08-05 | RSLS | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | S - Sale | $0.47 | -4,728 | 351,791 | -1% | -$2,222 | ||||||
| DM | 2022-08-09 | BDX | Becton Dickinson & Co | Khichi Samrat S. | EVP, GC | S - Sale+OE | $260.44 | -16,480 | 5,928 | -74% | -$4,292,051 | |||||
| D | 2022-08-09 | BDX | Becton Dickinson & Co | Polen Thomas E Jr | EVP | S - Sale+OE | $260.00 | -1,652 | 28,878 | -5% | -$429,520 | |||||
2022-08-10 | IART | Integra Lifesciences Holdings Corp | Evoli Lisa | EVP,CHRO | S - Sale | $55.81 | -1,165 | 17,997 | -6% | -$65,020 | ||||||
| D | 2022-08-11 | INO | Inovio Pharmaceuticals, Inc. | Weiner David B. | Dir | S - Sale+OE | $2.66 | -11,875 | 892,625 | -1% | -$31,588 | |||||
2022-08-05 | RSLS | Reshape Lifesciences Inc. | Bandy Barton P. | Pres, CEO | S - Sale | $0.47 | -11,674 | 773,098 | -1% | -$5,487 | ||||||
| M | 2022-08-09 | ATEC | Alphatec Holdings, Inc. | Pritzker Jennifer N. | 10% | P - Purchase | $7.99 | +8,100 | 14,192,050 | 0% | +$64,705 | |||||
| D | 2022-08-10 | MMM | 3M Co | Banovetz John Patrick | EVP | S - Sale+OE | $150.32 | -3,145 | 14,084 | -18% | -$472,764 | |||||
2022-08-08 | AXNX | Axonics, Inc. | Cohen Raymond W | CEO | S - Sale | $70.44 | -44,000 | 149,635 | -23% | -$3,099,326 | ||||||
2022-08-08 | TCMD | Tactile Systems Technology Inc | Reuvers Daniel L. | Pres, CEO | S - Sale | $9.18 | -1,020 | 74,707 | -1% | -$9,364 | ||||||
2022-08-09 | AORT | Artivion, Inc. | Maier Dennis B | SVP, Operations | S - Sale | $21.61 | -5,762 | 22,807 | -20% | -$124,513 | ||||||
| M | 2022-08-09 | SRTS | Sensus Healthcare, Inc. | O'Rear Samuel | Dir | S - Sale | $14.20 | -50,000 | 123,570 | -29% | -$710,196 | |||||
2022-08-09 | VAPO | Vapotherm Inc | Arnerich Anthony L. | Dir | P - Purchase | $1.65 | +20,000 | 1,338,469 | +2% | +$32,940 | ||||||
| M | 2022-08-08 | FNA | Paragon 28, Inc. | Mvm Partners LLP | 10% | S - Sale | $19.51 | -68,303 | 28,545,887 | 0% | -$1,332,589 | |||||
2022-08-04 | MDXG | Mimedx Group, Inc. | Stein Robert Benjamin | Pres, Regenerative Med. | S - Sale | $3.62 | -19,500 | 314,505 | -6% | -$70,590 | ||||||
2022-08-05 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale | $53.01 | -3,362 | 41,270 | -8% | -$178,229 | ||||||
2022-08-04 | TCMD | Tactile Systems Technology Inc | Burke William W | Dir | P - Purchase | $9.15 | +4,900 | 24,436 | +25% | +$44,835 | ||||||
| M | 2022-08-04 | IONM | Assure Holdings Corp. | Awm Investment Company, Inc. | below 10% | S - Sale | $3.94 | -799,403 | 750,000 | -52% | -$3,151,872 | |||||
2022-08-05 | IART | Integra Lifesciences Holdings Corp | Murphy Raymond G. | Dir | S - Sale | $55.78 | -8,000 | 69,586 | -10% | -$446,266 | ||||||
| M | 2022-08-04 | FNA | Paragon 28, Inc. | Mvm Partners LLP | 10% | S - Sale | $19.45 | -82,100 | 14,332,095 | -1% | -$1,596,904 | |||||
2022-08-04 | STSS | Sharps Technology Inc. | Hayes Robert Michael | CEO | P - Purchase | $1.15 | +2,000 | 32,000 | +7% | +$2,290 | ||||||
| M | 2022-08-03 | TMCI | Treace Medical Concepts, Inc. | Timbie Thomas E | Dir | S - Sale | $18.76 | -150,000 | 1,886,364 | -7% | -$2,813,966 | |||||
2022-08-04 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $37.71 | -3,072 | 16,928 | -15% | -$115,845 | ||||||
| D | 2022-08-03 | NASD | Abiomed Inc | Trapp Todd A | VP, CFO | S - Sale+OE | $300.00 | -1,000 | 16,927 | -6% | -$300,000 | |||||
| D | 2022-08-04 | MMM | 3M Co | Dickson Zoe L | EVP, CHRO | S - Sale+OE | $144.40 | -2,265 | 1,155 | -66% | -$327,070 | |||||
2022-08-03 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale | $240.72 | -1,545 | 105,286 | -1% | -$371,912 | ||||||
2022-08-02 | BSX | Boston Scientific Corp | Connors Nelda J | Dir | S - Sale | $41.58 | -16,088 | 50,319 | -24% | -$668,939 | ||||||
2022-08-02 | NARI | Inari Medical, Inc. | Milder Donald B | Dir | S - Sale | $80.44 | -21,000 | 3,673,220 | -1% | -$1,689,209 | ||||||
2022-08-03 | NVCR | Novocure Ltd | Benaim Ely | Chief Medical Officer | S - Sale | $73.73 | -5,959 | 28,672 | -17% | -$439,328 | ||||||
2022-08-01 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $137.12 | -88 | 3,872 | -2% | -$12,067 | ||||||
| D | 2022-08-01 | MMSI | Merit Medical Systems Inc | Peterson Neil | COO | S - Sale+OE | $58.10 | -4,000 | 0 | -100% | -$232,400 | |||||
2022-08-02 | NVCR | Novocure Ltd | Doyle William F | Exec COB | S - Sale | $69.66 | -837 | 551,176 | 0% | -$58,305 | ||||||
2022-08-02 | NVCR | Novocure Ltd | Benaim Ely | Chief Medical Officer | S - Sale | $69.66 | -437 | 34,631 | -1% | -$30,441 | ||||||
2022-08-02 | NVCR | Novocure Ltd | Leonard Frank X | Chief Development Officer | S - Sale | $69.66 | -414 | 102,193 | 0% | -$28,839 | ||||||
2022-08-02 | IART | Integra Lifesciences Holdings Corp | Mosebrook Jeffrey | SVP, Fin, Princ Acct Officer | S - Sale | $56.78 | -437 | 8,831 | -5% | -$24,811 | ||||||
2022-08-01 | NARI | Inari Medical, Inc. | Hykes Andrew | COO | S - Sale | $78.67 | -5,000 | 141,641 | -3% | -$393,359 | ||||||
2022-07-26 | MODD | Modular Medical, Inc. | Sheibley Philip Brent | Dir | P - Purchase | $4.12 | +2,000 | 10,139 | +25% | +$8,240 | ||||||
| D | 2022-08-02 | MMM | 3M Co | Vale Michael G. | Group Pres | S - Sale+OE | $143.26 | -36,771 | 65,321 | -36% | -$5,267,683 | |||||
2022-08-01 | BSX | Boston Scientific Corp | Thepaut Eric Francis Yves | EVP, Pres, Eur, Mid-East, Afr | S - Sale | $40.99 | -20,676 | 72,486 | -22% | -$847,509 | ||||||
| D | 2022-08-01 | TMCI | Treace Medical Concepts, Inc. | Owens Daniel E. | CHRO | S - Sale+OE | $16.89 | -1,000 | 10,700 | -9% | -$16,890 | |||||
2022-08-01 | TELA | Tela Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.96 | +4,979 | 1,666,179 | 0% | +$39,632 | ||||||
| M | 2022-07-26 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.02 | -150,000 | 38,705,000 | 0% | -$2,945 | |||||
2022-07-29 | STSS | Sharps Technology Inc. | Hayes Robert Michael | CEO | P - Purchase | $1.02 | +2,300 | 30,000 | +8% | +$2,352 | ||||||
| D | 2022-08-01 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale+OE | $143.32 | -795 | 2,101 | -27% | -$113,939 | |||||
2022-07-29 | ANGO | Angiodynamics Inc | Helsel Dave | SVP Global Operations, R, D | S - Sale | $22.44 | -5,000 | 23,822 | -17% | -$112,200 | ||||||
2022-07-27 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $135.00 | -88 | 3,960 | -2% | -$11,880 | ||||||
2022-07-26 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Pres, CCO | S - Sale | $208.28 | -4,000 | 74,563 | -5% | -$833,119 | ||||||
2022-07-25 | STIM | Neuronetics, Inc. | Furlong Stephen | CFO | S - Sale | $3.54 | -13,321 | 390,949 | -3% | -$47,156 | ||||||
| D | 2022-07-22 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $235.00 | -7,500 | 106,426 | -7% | -$1,762,500 | |||||
2022-07-21 | SILK | Silk Road Medical Inc | Weatherman Elizabeth H | Dir | S - Sale | $41.91 | -5,000 | 229,454 | -2% | -$209,550 | ||||||
2022-07-25 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP MD Dexcom V | S - Sale | $83.07 | -1,000 | 138,700 | -1% | -$83,070 | ||||||
2022-07-22 | TELA | Tela Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.02 | +5,200 | 1,664,200 | 0% | +$41,709 | ||||||
2022-07-20 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale | $206.44 | -3,000 | 15,796 | -16% | -$619,322 | ||||||
| D | 2022-07-20 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $207.09 | -1,350 | 39,938 | -3% | -$279,572 | |||||
2022-07-21 | TELA | Tela Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.03 | +10,333 | 1,659,000 | +1% | +$83,010 | ||||||
2022-07-20 | DCTH | Delcath Systems, Inc. | Michel Gerard J | CEO | P - Purchase | $3.98 | +62,814 | 125,864 | +100% | +$250,000 | ||||||
| M | 2022-07-18 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $16.10 | -34,200 | 1,792,624 | -2% | -$550,671 | |||||
2022-07-20 | TELA | Tela Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $8.08 | +5,100 | 1,648,667 | 0% | +$41,192 | ||||||
2022-07-18 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $75.29 | -5,275 | 518,899 | -1% | -$397,155 | ||||||
| D | 2022-07-20 | INO | Inovio Pharmaceuticals, Inc. | Benito Simon X | Dir | S - Sale+OE | $2.25 | -2,000 | 75,305 | -3% | -$4,500 | |||||
2022-07-08 | ECIA | Encision Inc | Geary Peter D | Dir of Strategic Integration | P - Purchase | $0.41 | +40,000 | 40,000 | New | +$16,400 | ||||||
| D | 2022-07-15 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $73.23 | -7,500 | 80,499 | -9% | -$549,201 | |||||
2022-07-18 | STIM | Neuronetics, Inc. | Sullivan Keith J | Pres, CEO | S - Sale | $3.72 | -63,466 | 850,999 | -7% | -$236,094 | ||||||
2022-07-15 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $14.28 | -2,116 | 233,452 | -1% | -$30,215 | ||||||
2022-07-15 | SIBN | Si-Bone, Inc. | Pisetsky Michael A | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $14.28 | -355 | 123,369 | 0% | -$5,069 | ||||||
2022-07-15 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $14.28 | -588 | 174,726 | 0% | -$8,396 | ||||||
2022-07-18 | BSX | Boston Scientific Corp | Carruthers Wendy | EVP, HR | S - Sale | $38.00 | -7,500 | 124,913 | -6% | -$285,000 | ||||||
2022-07-14 | STSS | Sharps Technology Inc. | Hayes Robert Michael | CEO | P - Purchase | $1.04 | +2,700 | 27,700 | +11% | +$2,802 | ||||||
| D | 2022-07-15 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $224.94 | -5,675 | 414,230 | -1% | -$1,276,517 | |||||
| M | 2022-07-14 | FNA | Paragon 28, Inc. | Jarboe Matthew | Chief Commercial Officer | S - Sale | $19.02 | -86,111 | 225,295 | -28% | -$1,637,815 | |||||
| M | 2022-07-13 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $16.14 | -15,800 | 1,826,824 | -1% | -$255,006 | |||||
2022-07-14 | SPNE | Seaspine Holdings Corp | Standish Beau | Pres, Enabling Tech | S - Sale | $5.73 | -50,000 | 0 | -100% | -$286,500 | ||||||
| M | 2022-07-11 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $8.02 | +15,000 | 3,605,709 | 0% | +$120,350 | |||||
| D | 2022-07-11 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $40.44 | -30,000 | 330,042 | -8% | -$1,213,194 | |||||
2022-07-08 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $75.17 | -11,237 | 524,174 | -2% | -$844,657 | ||||||
2022-07-08 | SILK | Silk Road Medical Inc | Weatherman Elizabeth H | Dir | S - Sale | $41.91 | -10,000 | 234,454 | -4% | -$419,100 | ||||||
2022-07-08 | FNA | Paragon 28, Inc. | Jarboe Matthew | Chief Commercial Officer | S - Sale | $19.44 | -63,889 | 311,406 | -17% | -$1,242,213 | ||||||
2022-07-08 | STIM | Neuronetics, Inc. | Macan William Andrew | SVP, GC, CCO, Secretary | S - Sale | $3.60 | -2,746 | 356,388 | -1% | -$9,886 | ||||||
2022-07-07 | IRTC | Irhythm Technologies, Inc. | Devine Douglas | COO, CFO | S - Sale | $114.22 | -10,109 | 29,702 | -25% | -$1,154,650 | ||||||
| M | 2022-07-06 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $7.96 | +15,000 | 3,590,709 | 0% | +$119,450 | |||||
| DM | 2022-07-06 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale+OE | $72.95 | -43,488 | 535,411 | -8% | -$3,172,344 | |||||
| DM | 2022-04-01 | AXNX | Axonics, Inc. | Kiernan Jane E | Dir | S - Sale+OE | $60.68 | -7,000 | 14,761 | -32% | -$424,743 | |||||
2022-07-05 | IRTC | Irhythm Technologies, Inc. | Wilson Daniel G. | EVP, Strategy Corp Dev Inv Rel | S - Sale | $108.93 | -1,428 | 37,562 | -4% | -$155,553 | ||||||
2022-07-05 | IRTC | Irhythm Technologies, Inc. | Devine Douglas | COO, CFO | S - Sale | $108.90 | -1,239 | 39,811 | -3% | -$134,925 | ||||||
2022-07-05 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $123.64 | -248 | 4,469 | -5% | -$30,663 | ||||||
2022-07-01 | PEN | Penumbra Inc | Sarna Surbhi | Dir | S - Sale | $124.39 | -27 | 1,980 | -1% | -$3,359 | ||||||
2022-07-05 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale | $212.33 | -1,545 | 106,831 | -1% | -$328,050 | ||||||
2022-07-05 | NARI | Inari Medical, Inc. | Hykes Andrew | COO | S - Sale | $70.31 | -5,000 | 146,641 | -3% | -$351,550 | ||||||
| D | 2022-07-05 | TMCI | Treace Medical Concepts, Inc. | Owens Daniel E. | CHRO | S - Sale+OE | $15.00 | -1,000 | 10,700 | -9% | -$15,000 | |||||
2022-07-05 | HAE | Haemonetics Corp | Miller Laurie A. | SVP, HR | S - Sale | $66.18 | -42 | 12,909 | 0% | -$2,780 | ||||||
| D | 2022-07-01 | PODD | Insulet Corp | Petrovic Shacey | Dir | S - Sale+OE | $222.90 | -15,000 | 101,258 | -13% | -$3,343,500 | |||||
2022-07-01 | RSLS | Reshape Lifesciences Inc. | Stankovich Thomas | CFO | S - Sale | $0.55 | -4,630 | 356,519 | -1% | -$2,547 | ||||||
2022-07-01 | RSLS | Reshape Lifesciences Inc. | Bandy Barton P. | Pres, CEO | S - Sale | $0.55 | -11,442 | 784,772 | -1% | -$6,293 | ||||||
| M | 2022-06-29 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.02 | -150,000 | 38,855,000 | 0% | -$2,645 | |||||
| M | 2022-06-30 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $7.29 | +15,000 | 3,575,709 | 0% | +$109,300 | |||||
2022-07-01 | TELA | Tela Bio, Inc. | Opaleye Management Inc. | 10% | P - Purchase | $7.00 | +200 | 98,567 | 0% | +$1,400 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |